Inhaled activated protein C protects mice from ventilator-induced lung injury.
BACKGROUND
Activated Protein C (APC), an endogenous anticoagulant, improves tissue microperfusion and endothelial cell survival in systemic inflammatory states such as sepsis, but intravenous administration may cause severe bleeding. We have thus addressed the role of APC delivered locally by inhalation in preventing acute lung injury from alveolar overdistention and the subsequent ventilator-induced lung injury (VILI). We also assessed the effects of APC on the activation status of Extracellular- Regulated Kinase 1/2 (ERK) pathway, which has been shown to be involved in regulating pulmonary responses to mechanical stretch.


METHODS
Inhaled APC (12.5 microg drotrecogin-alpha x 4 doses) or saline was given to tracheotomized C57/Bl6 mice starting 20 min prior to initiation of injurious mechanical ventilation with tidal volume 25 mL/Kg for 4 hours and then hourly thereafter; control groups receiving inhaled saline were ventilated with 8 mL/Kg for 30 min or 4 hr. We measured lung function (respiratory system elastance H), arterial blood gases, surrogates of vascular leak (broncho-alveolar lavage (BAL) total protein and angiotensin-converting enzyme (ACE)-activity), and parameters of inflammation (BAL neutrophils and lung tissue myeloperoxidase (MPO) activity). Morphological alterations induced by mechanical ventilation were examined in hematoxylin-eosin lung tissue sections. The activation status of ERK was probed in lung tissue homogenates by immunoblotting and in paraffin sections by immunohistochemistry. The effect of APC on ERK signaling downstream of the thrombin receptor was tested on A549 human lung epithelial cells by immunoblotting. Statistical analyses were performed using ANOVA with appropriate post-hoc testing.


RESULTS
In mice subjected to VILI without APC, we observed hypoxemia, increased respiratory system elastance and inflammation, assessed by BAL neutrophil counts and tissue MPO activity. BAL total protein levels and ACE activity were also elevated by VILI, indicating compromise of the alveolo-capillary barrier. In addition to preserving lung function, inhaled APC prevented endothelial barrier disruption and attenuated hypoxemia and the inflammatory response. Mechanistically, we found a strong activation of ERK in lung tissues by VILI, which was prevented by APC, suggestive of pathogenetic involvement of the Mitogen-Activated Kinase pathway. In cultured human lung epithelial cells challenged by thrombin, APC abrogated the activation of ERK and its downstream effector, cytosolic Phospholipase A2.


CONCLUSIONS
Topical application of APC by inhalation may effectively reduce lung injury induced by mechanical ventilation in mice.
Maniatis
Nikolaos A
NA
2nd Dept, of Critical Care, Attikon Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1, Haidari, Greece. maniatisnikolaos@yahoo.com
Letsiou
Eleftheria
E
Orfanos
Stylianos E
SE
Kardara
Matina
M
Dimopoulou
Ioanna
I
Nakos
Georgios
G
Lekka
Marilena E
ME
Roussos
Charalambos
C
Armaganidis
Apostolos
A
Kotanidou
Anastasia
A
D000280:Administration, Inhalation; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage* / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011486:Protein C / Q000008:administration & dosage* / Q000494:pharmacology*; D055397:Ventilator-Induced Lung Injury / Q000517:prevention & control*
D000925:Anticoagulants; D011486:Protein C
Blood. 2004 Dec 15;104(13):3878-85
15339848
Crit Care. 2008;12(4):R103
18691424
Eur Respir J. 2002 Oct;20(4):946-56
12412688
Cell Signal. 2006 Dec;18(12):2200-8
16806823
Biochem Biophys Res Commun. 2008 Feb 22;366(4):1030-5
18086557
Anesthesiology. 2009 Oct;111(4):826-35
19741487
Crit Care Med. 2005 Apr;33(4):772-9
15818104
Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L1002-11
19363121
N Engl J Med. 2000 May 4;342(18):1301-8
10793162
PLoS One. 2009;4(2):e4600
19240800
Intensive Care Med. 2005 Jun;31(6):776-84
15812622
Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L43-54
12788788
Am J Respir Crit Care Med. 2001 Jun;163(7):1660-8
11401891
Intensive Care Med. 2010 Feb;36(2):222-31
20069275
Crit Care Med. 2006 Jul;34(7):1918-24
16715034
Br J Anaesth. 2008 Jun;100(6):815-9
18424805
Respir Res. 2004 Nov 27;5:23
15566575
N Engl J Med. 2001 Mar 8;344(10):699-709
11236773
PLoS One. 2008 Feb 13;3(2):e1601
18270588
Am J Respir Crit Care Med. 2005 Jun 15;171(12):1328-42
15695492
Methods Mol Biol. 2009;466:205-21
19148608
J Appl Physiol (1985). 2003 Apr;94(4):1297-306
12626466
Proc Am Thorac Soc. 2005;2(3):243-7
16222045
Crit Care Med. 2007 Aug;35(8):1821-8
17667242
Am J Respir Crit Care Med. 1998 Jan;157(1):294-323
9445314
Am J Respir Crit Care Med. 2010 May 1;181(9):947-56
20110555
Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):1835-46
8520744
Blood. 2007 Apr 15;109(8):3161-72
17110453
Annu Rev Physiol. 2006;68:585-618
16460285
J Appl Physiol (1985). 2005 Aug;99(2):723-30
15831795
Lung. 2004;182(6):319-30
15765924
Curr Opin Crit Care. 2005 Feb;11(1):82-6
15659950
Am J Respir Crit Care Med. 2009 Nov 1;180(9):861-6
19696442
Crit Care Med. 2006 Sep;34(9):2432-8
16810106
Am J Respir Crit Care Med. 2006 Jul 15;174(2):187-97
16645177
Biochem J. 2003 Jul 1;373(Pt 1):65-70
12683950
J Appl Physiol (1985). 2008 Oct;105(4):1282-90
18669934
Physiol Rev. 2006 Jan;86(1):279-367
16371600
Circulation. 2000 Oct 17;102(16):2011-8
11034953
Am J Respir Cell Mol Biol. 2007 Apr;36(4):497-503
17099142
Crit Care. 2007;11(1):R25
17316425
Am J Respir Cell Mol Biol. 2009 Oct;41(4):426-32
19202007
Eur Respir J. 2003 Mar;21(3):495-501
12662008
Am J Respir Crit Care Med. 2008 Sep 15;178(6):618-23
18565951
Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1114-9
9351610
Lancet. 2007 Mar 10;369(9564):836-843
17350452
Semin Thromb Hemost. 2008 Jul;34(5):475-84
18956288
Blood. 2004 Mar 15;103(6):2196-204
14604971
J Appl Physiol (1985). 2008 Feb;104(2):354-62
18006865
Vascul Pharmacol. 2006 Aug;45(2):134-40
16959545
Eur Respir J. 2007 Dec;30(6):1216-26
18055706
Circ Res. 2006 Oct 13;99(8):870-7
16973909
Am J Physiol Lung Cell Mol Physiol. 2006 Sep;291(3):L345-53
16632522